These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4153360)

  • 21. Activation of opioid mu-receptor by sinomenine in cell and mice.
    Wang MH; Chang CK; Cheng JH; Wu HT; Li YX; Cheng JT
    Neurosci Lett; 2008 Oct; 443(3):209-12. PubMed ID: 18692550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
    Kest B; McLemore G; Kao B; Inturrisi CE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of morphine on the heart rate in normal or morphine-tolerant rats.
    Kaymakçalan S; Kayan S
    New Istanbul Contrib Clin Sci; 1967; 9(3):99-107. PubMed ID: 16300154
    [No Abstract]   [Full Text] [Related]  

  • 26. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
    Hernández-Delgadillo GP; Cruz SL
    Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ritanserin prolongs the analgesic effect of morphine and slows the development of tolerance].
    Verbitskaia EV; Kudriashova MF
    Eksp Klin Farmakol; 1997; 60(2):10-3. PubMed ID: 9206558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy II: narcotic and narcotic-antagonists analgesics.
    Gardier RW
    Dent Clin North Am; 1978 Jan; 22(1):125-41. PubMed ID: 23324
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on tolerance. II. The effect of timing on inhibition of tolerance to morphine by cycloheximide.
    Feinberg MP; Cochin J
    J Pharmacol Exp Ther; 1977 Nov; 203(2):332-9. PubMed ID: 909066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of morphine and naloxone on fetal heart rate and movement in the pig.
    Cohen S; Parvizi N; Mulder EJ; Van Oord HA; Jonker FH; Van Der Weijden GC; Taverne MA
    J Appl Physiol (1985); 2001 Apr; 90(4):1577-83. PubMed ID: 11247963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perinatal narcotic addiction in mice: sensitization to morphine stimulation.
    Shuster L; Webster GW; Yu G
    Addict Dis; 1975; 2(1-2):277-92. PubMed ID: 1172350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term suppression of pain by narcotic drugs in the absence of tolerance development.
    Colpaert FC
    Arch Int Pharmacodyn Ther; 1978 Dec; 236(2):293-5. PubMed ID: 34370
    [No Abstract]   [Full Text] [Related]  

  • 34. Naltrexone, morphine and cocaine interactions in mice and rats.
    Blumberg H; Ikeda C
    J Pharmacol Exp Ther; 1978 Aug; 206(2):303-10. PubMed ID: 682114
    [No Abstract]   [Full Text] [Related]  

  • 35. On the mechanism of tolerance to morphine-induced Straub tail reaction in mice.
    Zarrindast MR; Alaei-Nia K; Shafizadeh M
    Pharmacol Biochem Behav; 2001; 69(3-4):419-24. PubMed ID: 11509199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological properties of 2,3-dihydro-9H-isoxazolo [3,2-b] quinazolin-9-one (W-2429. Part 1: Analgesic, antipyretic and antiedema activity.
    Sofia RD; Diamantis W; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):770-82. PubMed ID: 17418
    [No Abstract]   [Full Text] [Related]  

  • 37. A new method for the rapid measurement of analgesic activity in rabbits.
    Ayhan IH; Türker RK; Melli M
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):215-20. PubMed ID: 6135398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability.
    Crain SM; Shen KF
    Pain; 2000 Feb; 84(2-3):121-31. PubMed ID: 10666516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective interaction of homophtalazine derivatives with morphine.
    Fekete MI; Horváth K; Kedves R; Máté I; Székely JI; Szentkuti E
    Eur J Pharmacol; 1997 Jul; 331(2-3):175-83. PubMed ID: 9274977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chronic morphinization on calcium membrane interaction.
    Ross DH; Lynn SC; Jones DJ
    Proc West Pharmacol Soc; 1976; 19():66-70. PubMed ID: 996028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.